Table 1 Baseline patient characteristics of patients with esophageal squamous cell carcinoma
Clinicopathological | Total |
|---|---|
variables | N = 64 (%) |
Sex | |
 Male/Female | 60 (93.8)/4 (6.2) |
Age, median years | 63.5 |
Smoking (pack-yrs) | |
 Light/Heavy | 29 (45.3)/35 (54.7) |
Alcohol (drink/week) | Â |
 Light/Heavy | 32 (50.0)/32 (50.0) |
Location | |
 Upper/Middle/Lower | 14 (21.9)/31 (48.4)/19 (29.7) |
Tumor size, median (range, mm) | 36.5 (8–105) |
Differentiation | |
 Well/Moderate/Poor | 26 (40.6)/26 (40.6)/12 (18.8) |
pT category | |
 T1/T2/T3/T4 | 27 (42.2)/9 (14.1)/27 (42.2)/1 (1.5) |
pN category | |
 N0/N1/N2/N3 | 39 (60.9)/14 (21.9)/7 (10.9)/4 (6.3) |
pM category | |
 M0/M1 | 64 (100)/0 (0) |
AJCC stage (8th) | |
 IA/IB | 3 (4.7)/23 (35.9) |
 IIA/IIB | 9 (14.1)/5 (7.8) |
 IIIA/IIIB | 4 (6.3)/15 (23.4) |
 IVA | 5 (7.8) |
Treatment | |
 Surgery alone | 47 (73.4) |
 Surgery and CT | 7 (10.9) |
 Surgery and RT | 1 (1.6) |
 Surgery and CCRT | 9 (14.1) |
Resection margin status | |
 Negative (R0)/Positive (R1) | 57 (89.1)/7 (10.9) |
Recurrence | |
 No/Yes | 24 (37.5)/40 (62.5) |
Survival status (at follow-up) | |
 Alive/Dead | 26 (40.6)/38 (59.4) |
Family history of malignancy | 2 (3.1) |
Metachronous/synchronous malignancy | 17 (26.6) |